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Hantaviruses  are  causative  agents  of two  rodent-borne  zoonoses,  hemorrhagic  fever with  renal  syndrome
(HFRS) and  nephropathia  epidemica  (NE)  in  the  Old  World  and  hantavirus  pulmonary  syndrome  (HPS)
in the New  World.  Serological  examinations  to detect  hantavirus  antibodies  have  been  most  widely0 November 2013
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lternative neutralization test
used  for  surveillance  among  humans  and rodent  reservoirs.  Here,  we  will  review  antigenic  structure  of
nucleocapsid  (N)  protein  of  hantaviruses  and  application  of  recombinant  N protein  as  diagnostic  antigen
for  screening  and serotyping.
© 2014  The  Authors.  Published  by  Elsevier  B.V.  Open access under CC BY-NC-ND license.. Introduction
Hantaviruses are classiﬁed in the family Bunyaviridae, genus
antavirus. So far, 24 virus species that represent serotypes and
enotypes have been registered within the genus Hantavirus
Plyusnin et al., 2012). Recently, antigenically and genetically dis-
inct hantaviruses have newly appeared from shrews, moles and
ats and have been recognized as new members of the hantavirus
enus (Arai et al., 2013; Hughes and Friedman, 2000; Kang et al.,
009; Vaheri et al., 2013; Weiss et al., 2012).
Among the various hantaviruses, rodent-borne hantaviruses
re known to cause two febrile diseases in humans, hemorrhagic
ever with renal syndrome (HFRS) in Eurasia and hantavirus pul-
onary syndrome (HPS) in North and South Americas (Nichol et al.,
993; Schmaljohn et al., 1985). Because of the variety of clinical
ymptoms, laboratory diagnosis is important for differentiation of
antavirus infection from other febrile infectious diseases.
Transmission of the viruses to humans occurs through inhala-
ion of contaminated aerosolized animal excreta or rodent bites.
Abbreviations: HFRS, hemorrhagic fever with renal syndrome; NE, nephropathia
pidemica; HPS, hantavirus pulmonary syndrome; ICG, immunochromatographic;
tnv, Hantaan virus; PUUV, Puumala virus; ANDV, Andes virus.
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Open access under CC BY-NC-ND Unlike other members of the Bunyaviridae family, no arthropod vec-
tor is involved in the hantavirus transmission cycle. Furthermore,
it is thought that human-to-human transmission of the infection
does not occur with the exception of HPS endemic in South America
(Martinez et al., 2005). Thus, early diagnosis of suspected patients
and surveillance of infected rodents are crucial for control and pre-
vention of hantavirus infection. Surveillance of hantavirus infection
has been done mainly by serological detection of hantavirus-
speciﬁc antibodies using enzyme-linked immunosorbent assay
(ELISA) and immunoﬂuorescent antibody assay. Various recombi-
nant nucleocapsid (N) proteins, produced by various expression
systems, such as Escherichia coli, baculovirus, chimeric HBV  core
particle and Drosophila melanogaster cells have been applied as
ELISA antigens (Brus Sjolander et al., 2000; Elgh et al., 1997; Ulrich
et al., 1998; Vapalahti et al., 1996; Wang et al., 1993).
Each hantavirus appears to have a single predominant animal
species as their natural reservoir. Furthermore, pathogenicity to
humans varies depending on the hantavirus species (Schmaljohn
and Hjelle, 1997). Since most of the hantavirus species represent
different serotypes, serological typing of infected hantavirus pro-
vides important epidemiologic information. The only serological
assay available to deﬁne the serotype of a causative hantavirus is
the neutralization test (Chu et al., 1995). However, the neutraliza-
tion test needs specialized techniques and equipment, takes 1–2
weeks to perform, and requires a containment laboratory for virus
manipulation. Thus, a rapid, simple and safe method to substitute
for the neutralization test is required. We have developed a recom-
binant N protein by E. coli and baculovirus expression systems and
applied it as an ELISA antigen for screening and serotyping (Araki
et al., 2001; Koma et al., 2010, 2012; Nakamura et al., 2008; Yasuda
license.
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Fig. 1. Phylogenetic tree of hantaviruses based on S genome segment. Diagnostic
antigen proposed in Fig. 7 was demonstrated as numbered circles. Abbreviations:
Group A – HTNV, Hantaan virus (GenBank ID: M14626); SEOV, Seoul, Sapporo
rat  virus (GenBank ID: M34881); DOBV, Dobrava-Belgrade virus (GenBank ID:
L41916); THAIV, Thailand virus (GenBank ID: L41916); DBSV, Da Bi Shan virus
(GenBank ID:AB027523); Group B – PUUV, Puumala virus (GenBank ID: X61035);
HOKV, Hokkaido virus (GenBank ID: AB010731); MUJV, Muju virus (GenBank ID:
DQ138128); TOPV, Topografov virus (GenBank ID: AJ011646); KHAV, Khabarovsk
virus (GenBank ID: U35255); TULV, Tula virus (GenBank ID: Z30941); ISLAV,
Isla Vista virus (GenBank ID: CVU19302); PHV, Prospect Hill virus (GenBank ID:
M34011); Group C – ANDV, Andes virus (GenBank ID: AF291702); BAYV, Bayou
virus (GenBank ID: L36929); CADV, Cano Delgadito virus (GenBank ID: DQ285566);
LNV, Laguna Negra virus (GenBank ID: AF005727); BCCV, Black Creek Canal virus
(GenBank ID: L39949); SNV, Sin Nombre virus (GenBank ID: AF281851); ELMCV,
El  Moro Canyon virus (GenBank ID: U11427); RIOMV, Rio Mamore virus (GenBank
ID:  U52136); CARV, Carrizal virus (GenBank ID: AB620093); ARAV, Araraquara virus
(GenBank ID: EF571895); LSCV, Limestone Canyon virus (GenBank ID: AF307322);
NYV, New York virus (GenBank ID: U09488); MULV, Muleshoe virus (GenBank
ID:  U54575); CHOV, Choclo virus (GenBank ID: DQ285046); Group D – TPMV,
Thottapalayam virus (GenBank ID: AY526097); MJNV, Imujin virus (GenBank
ID:EF641804); NVAV, Nova virus (GenBank ID: FJ539168) Group D – CBNV, Cao
Bang virus (GenBank ID: EF543524); ASAV, Asama virus (GenBank ID: EU929070);
APRV, Ash River virus (GenBank ID: EF650086); OXBV, Oxbow virus (GenBank ID:
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the heterologous group (Fig. 4) (Koma et al., 2012). This classiﬁca-J539166); JMSV, Jemez Springs virus (GenBank ID: FJ593499); SWSV, Seewis virus
GenBank ID: EF636024).
t al., 2012). More recently, immunodominant regions in N protein
xpressed by E. coli was applied for a rapid immunochromato-
raphic test (Amada et al., 2013).
In this chapter, antigenic characteristics of hantavirus N protein
re overviewed and then application of recombinant N protein in
he serotyping ELISA and ICG tests is introduced mainly according
o our recent observations.
. Antigenic characteristics of N protein of hantaviruses
Phylogenetic characterization of hantaviruses based on the
omparison of N protein-encoding sequences showed 4 major
roups (Fig. 1): group A consists of Murinae rodent-borne han-
aviruses and includes HFRS viruses, such as Hantaan (HTNV), Seoul
SEOV) and Dobrava/Belgrade (DOBV) viruses, group B consists
f Arvicolinae rodent-borne hantaviruses and includes HFRS virus
uch as Puumala virus (PUUV), group C consists of Sigmodonti-
ae and Neotominae rodent-borne hantaviruses that are causative
gents of HPS such as Sin Nombre (SNV), Andes (ANDV) and oth-
rs, and group D and E consists of shrew and mole viruses of which
he virulence to humans is unclear. The recently isolated bat-borne
antavirus would be included in group D, E, or neighboring lineage.esearch 187 (2014) 77–83
Epitope mapping studies of N protein with polyclonal immune
sera, patient sera and naturally infected rodent sera revealed that
N protein has an immunodominant antigenic region that is com-
posed of linear epitopes at around the ﬁrst 100 aa of the N terminus
(Elgh et al., 1996; Gott et al., 1997; Saasa et al., 2012; Tischler
et al., 2008; Yamada et al., 1995). The region is antigenically
cross-reactive among viruses in the same group but not to viruses in
different groups. On the other hand, conformation-dependent epi-
topes were located at the C-terminal half of N protein. Sandwich
ELISA with truncated recombinant N proteins (trNs) that lacked
the N-terminal 50 aa indicated that the conformation-dependent
epitope was  multimerization-dependent. Sera from HTNV, SEOV
and Thailand virus (THAIV)-infected patients reacted with homol-
ogous trN protein (Nakamura et al., 2008), suggesting that the
conformation-dependent epitopes at the C-terminal half of N pro-
tein are serotype-speciﬁc epitopes.
In the following sections, application of the recombinant N pro-
tein to screening and serotyping diagnoses is introduced.
3. Application of whole and truncated N proteins as
screening and serotyping antigens for ELISA
Based on the antigenic properties of N protein, it is speculated
that the whole N protein would be useful as a screening anti-
gen among viruses in the same group. On the other hand, it is
expected that deletion of the N-terminal immunodominant region
would decrease reactivity to cross-reactive antibodies but preserve
reactivity to serotype-speciﬁc antibodies after multimerization
(Yoshimatsu et al., 2003). If the cross-reactivity was decreased, the
truncated N (trN) protein would be useful as a serotyping antigen
in ELISA.
As expected, trN proteins that lacked the N-terminal 49 aa
(trN50) of HTNV, SEOV, and DOBV showed decreased reactivity
to heterologous immune sera but preserved reactivity to homolo-
gous immune serum (Fig. 2). Whereas the whole N protein reacted
equally to heterologous immune sera. On the other hand, PUUV,
which belonged to group B, showed a signiﬁcant antigenic differ-
ence to group A viruses (Araki et al., 2001). In addition to trN50
antigens of HTNV, SEOV and DOBV, trN50 of THAIV has been devel-
oped (Nakamura et al., 2008). This trN50 protein-based ELISA was
also applicable for serotyping with patient sera and rodent sera
(Chandy et al., 2009; Gamage et al., 2011; Yasuda et al., 2002).
The same strategy was  applied to group C viruses that included
causative agents of HPS, such as SNV, ANDV and LANV. The trN
protein that lacks 99 aa at the N-terminus (trN100) can be applied
as a serotyping antigen after multimerization (Koma et al., 2010).
The ELISA OD values of heterologous antigens were less than half
of those of homologous reactions in most of the sera from patients
and from naturally infected rodents.
Applicability of the trN100 antigens for serological differentia-
tion among hantaviruses in North and South America (New World
hantaviruses) was  examined. Based on the nucleotide and aa iden-
tities of the variable region (230–302 aa and 690–906 nucleotides)
of N proteins, a total of 28 New World hantaviruses were divided
into ﬁve groups (groups 1–5) with 70–80% aa identities as a ten-
tative criterion. These hantaviruses were also grouped into ﬁve
corresponding groups geographically and phylogenetically (Fig. 3).
TrN100 of SNV (group 1), ANDV and Lagna negra virus (LANV)
(group 2), Black Creek Canal virus (BCCV) (group 3) and El Molo
Canyon virus (ELMCV) and Carizale virus (CARV) (group 4) were
serologically differentiated either with patient or rodent sera oftion corresponds basically to a suggested classiﬁcation based on the
entire aa sequences of S and M segments (Maes et al., 2009). How-
ever, this classiﬁcation was not adopted by the ICTV Bunyaviridae
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Fig. 2. Reaction patterns of rNPs with rabbit immune sera in ELISA. (A) Whole rNs; (B) trN50s; HTNV (closed diamond), SEOV (closed square), DOBV (closed triangle), and
P d sub
t nti-DO
s
t
p
t
a
i
s
g
c
4
e
(
ﬂ
t
o
b
h
e
(
a
l
s
d
W
R
i
4
i
eUUV  (open circle) rNs were used. Each antigen was diluted from 1:10 to 1:5120 an
hen  detected with various rabbit immune sera: (a) anti-HTNV; (b) anti-SEOV; (c) a
tudy group. The correspondence might be explained by the fact
hat reassortment of the virus S genome segment that encodes N
rotein rarely occurs between viruses in different clades. Therefore,
he trN100-based ELISA will become a valuable tool for surveying
nd serotyping human and rodent cases of New World hantavirus
nfection as a useful substitute for the neutralization test. These
erotyping antigens for hantaviruses belonging to group A and
roup C are shown in Figs. 1 and 7 as #1–#4 and #5–#9 with open
ircles.
. Application of immunodominant antigenic region
xpressed by E. coli for a rapid immunochromatographic
ICG) test for rat and human sera
An immunochromatographic (ICG) test is a strip-based lateral
ow immunoassay by detecting migration of nanoparticles along
he membrane. The ICG test has been used widely for diagnoses
f various infectious diseases by detecting an antigen or anti-
ody against pathogens. An ICG test for hantavirus serodiagnoses
as been developed for detecting IgM antibody in PUUV (Hujakka
t al., 2001a, 2001b) DOBV/HTNV (Hujakka et al., 2003) and ANDV
Navarrete et al., 2007) patient serum. In ﬁeld surveys in bank voles,
n ICG test for detecting IgG antibody to PUUV in sera from Norway
emmings and sibling voles was developed (Sirola et al., 2004). High
ensitivities and speciﬁcities were obtained in both IgM antibody
etection in patient sera and IgG antibody detection in rodent sera.
e have developed an ICG test for detecting hantavirus antibody in
attus serum and human serum by using N-terminal immunodom-
nant regions of N protein.
.1. ICG test for Rattus serumIt is known that each of the hantaviruses has its own  predom-
nant reservoir animal species as a natural reservoir. Therefore,
ndemic areas of HFRS and HPS-causing hantavirus have beenjected to capture ELISA. Antigens were captured by monoclonal antibody E5G6 and
BV; (d) anti-PUUV. All sera were diluted at 1:200.
conﬁned to areas inhabited by speciﬁc reservoir rodents. However,
the distribution of SEOV carried by the brown rat (Ratus norvegicus)
has been found worldwide, probably due to the migration of rodent
reservoirs through international transportation by ship. Further-
more, SEOV is a causative agent of laboratory rat-associated HFRS in
institutions and universities in Asia and Europe. Therefore, surveil-
lance of SEOV infection both among urban rats and laboratory rats
is necessary worldwide. We  have developed an ICG test speciﬁcally
to detect SEOV IgG antibody among urban rats and laboratory rats
as a simple and rapid diagnostic method (Amada et al., 2013). In
the ICG test, the N-terminal 103 aa of HTNV that is expressed by
E. coli was used as an antigen, since this region is almost completely
identical to that of SEOV. Rabbit anti-rat IgG-labeled colloidal gold
was used as a carrier. Typical ICG patterns of antibody-positive and
antibody-negative sera are shown in Fig. 5. The ICG test showed
almost the same antibody detection sensitivity as that of ELISA and
about 10-times higher sensitivity than that of IFA. A total of 340 rat
sera including 19 experimentally infected laboratory rat sera, 38
naturally infected sera and 283 uninfected laboratory rat and urban
rat sera were examined. The ICG test detected the antibody at the
same level as that of ELISA. The sensitivity and speciﬁcity of ICG
compared to ELISA and/or IFA were 100% and 99.8%, respectively.
Since the antigen used in this ICG contains a cross-reacted epitope
among Murinae rodent-borne hantaviruses, the ICG test can detect
antibodies against HTNV, DOBV and THAIV. Furthermore, diluted
blood specimens (about 1:30) could be applied directly onto ICG
strips and gave clear ICG patterns with the same sensitivity as that
with ordinary serum. Thus, the ICG test is a rapid, simple and safe
method for diagnosis of SEOV infection in rats, particularly in ﬁeld
surveys.4.2. ICG test for human serum
As mentioned above, because of the close association between
the hantavirus species and their rodent host, epidemic areas
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Fig. 3. Distribution map  of grouped New World hantaviruses and phylogenetic tree for New World hantavirus. (A) The map  represents the geographical distribution of
grouped New World hantaviruses. (B) Phylogenetic tree for New World hantavirus. Neighbor-joining phylogenetic analysis was performed on the basis of partial aa sequence
of  the N protein (aa residues 230–302). An asterisk (*) indicates that human cases of infection with the virus have been reported. Abbreviations: AAIV, Ape Aime Itapua virus,
Hantavirus strain IP16 (GenBank ID: DQ345764); ALPV, Alto Paraguay virus (GenBank ID: DQ345762); ANAV, Anajatuba virus (GenBank ID: DQ451829); ANDV Chile, Andes
virus  Chile-9717869 (GenBank ID: AF291702); ANDV Nort, Andes virus AND Nort (GenBank ID: AF325966); ARA like, Araraquara-like virus strain P5/Cajuru (GenBank ID:
EF571895); BAYV, Bayou virus (GenBank ID: L36929); BCCV, Black Creek Canal virus (GenBank ID: L39949); BMJV, Bermejo virus (GenBank ID: AF482713); CARV, Carrizal virus
(GenBank ID: AB620093); CATV, Catacamas virus (GenBank ID: DQ256126); CC107, SNV strain Convict Creek 107 virus (GenBank ID: L33683); CADV, Cano Delgadito virus
(GenBank ID: DQ285566); CHOV, Choclo virus (GenBank ID: DQ285046); DOBV, Dobrava-Belgrade virus (GenBank ID: L41916); ELMCV, El Moro Canyon virus (GenBank ID:
U11427);  HTNV, Hantaan virus (GenBank ID: M14626); HTN-007, Hantavirus HTN-007 (GenBank ID: AF133254); Hu39694, Hu39694, Hantavirus sp. (GenBank ID: AF482711);
IP37,  Hantavirus strain Itapua 37 (GenBank ID: DQ345765); IP38, Hantavirus strain Itapua 38 (GenBank ID: DQ345766); JUQV, Juquitiba virus (GenBank ID: EF492472); LANV,
Laguna  Negra virus (GenBank ID: AF005727); LECV, Lechiguanas virus (GenBank ID: AF482714); LSCV, Limestone Canyon virus (GenBank ID: AF307322); MCLV, Maciel virus
(GenBank ID: AF482716); MAPV, Maporal virus (GenBank ID: AY267347); MGLV, Hantavirus Monongahela-1 (GenBank ID: U32591); MULV, Muleshoe virus (GenBank ID:
U54575); NEBV, Neembucu hantavirus (GenBank ID: DQ345763); NYV, New York virus (GenBank ID: U09488); ORNV, Oran virus (GenBank ID: AF482715); OROV, Playa de
Oro  hantavirus (GenBank ID: EF534079); PRGV, Pergamino virus (GenBank ID: AF482717); PUUV, Puumala virus (GenBank ID: X61035); RIOMV, Rio Mamore virus (GenBank
ID:  U52136); RMEV, Rio Mearim virus (GenBank ID: DQ451828); RIOSV, Rio Segundo virus (GenBank ID: U18100); SEOV, Seoul, Sapporo rat virus (GenBank ID: M34881);
S
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1. Screening assay
By ELISA or ICG
(N-terminal 103 aa of N)
HTNV
SEOV
DOBV
THAIV
HTNV
PUUV
PUUV
TULV
Other s
ANDV
TPMV and  others
ANDV
LANV
SNV
Other s
2. Serotyping assay
By FRNT or ELISA
(C-terminal half of N)
SEOV
Rapid serological diagnosis and serotyping
Idenﬁcaon of reservoir anim
als
2
3
1
1
2
3
4
5
6
7
B
A
C
D, E
Paent sera or anim
al sera
Fig. 7. The chart of serological diagnosis of hantavirus infection. N-terminal region
of  N proteins (1–3 on closed circle) were useful for screening hantavirus infections.
Then serotyping assay was necessary to differentiate viruses. A set of C-terminal half
of  N proteins (1–4 on open circle) were useful for serotyping assay as alternative
method of neutralization test for group A viruses and the other set of serotypingig. 5. Cross-reactivity of the ICG test. Immune rat sera against two  viruses. (S):
EOV; (H): HNTV; (-): uninfected.
f HFRS and HPS depend on the rodent habitat. Therefore, it is
enerally not necessary to deﬁne serotypes of infected hantavirus
n an endemic area. However, imported cases of HFRS and HPS
etween different countries and continents have been reported. In
ome countries, multiple hantaviruses are co-circulating. There-
ore, screening of antibodies to all of the serotypes of HFRS and HPS
ausing hantavirus is necessary so as not to overlook hantavirus
nfections.
Based on this background, the N-terminal part of N protein that
ossesses a cross-reacted immnodominant region was applied to
he ICG test for antibody screening. For this purpose, N-terminal
03 aa of N protein of HTNV, PUUV and ANDV were selected as rep-
esentative antigens of the antigenic groups A, B and C, respectively.
hese proteins were expressed as NUS and his-tagged recombinant
ntigens by an E. coli expression system and are shown as #1, #2,
nd #3 antigens with closed circle in Figs. 1 and 7. For the screening
ntigen for group D and E hantaviruses, we tentatively prepared
hottapalayam (TPMV) and Asama virus (ASAV) antigen shown as
sterisk with closed circle (Okumura et al., 2007; Schlegel et al.,
012). However these antigens might not cover groups D and E
iruses, respectively. Further investigation to choose the screening
ntigen for all of the group D and E viruses was needed. By using
1, #2, and #3 screening antigens, three different types of ICG strip
ere prepared as shown in Fig. 6: a one-antigen strip that has one
f HTNV, PUUV or ANDV antigen line on the ICG strip, a mixed-
ine strip that has one antigen line with mixed antigens of HTNV,
UUV and ANDV, and a three-line strip that has 3 antigen lines of
TNV, PUUV and ANDV antigens on the same ICG strip. Protein
A: Single angen
B: Three-line angen
C: Mixed-line angen
HFRS strip
NE strip
HPS strip
Control lineTest line(s)
SEO
PUU
AND
ig. 6. Design of ICG strips. (A) Single antigen strip, HFRS strip with N-terminal
03 aa of HTNV N protein; NE strips with N-terminal 103 aa of PUUV N protein;
PS  strip with N-terminal 103 aa of ANDV N protein; (B) three-line antigen strip;
-terminal 103 aa of HTNV, PUUV, and ANDV N proteins were put on one strip; (C)
ixed-line antigen strip; mixture of N-terminal 103 aa of HTNV, PUUV, and ANDV
 proteins were put on one strip.antigens (5–7) were prepared for group C viruses. Recombinant N antigens of TPMV
and ASAV for group D and E viruses were shown as closed circle with asterisk of
Fig  1.
A-labeled colloidal gold (EY Laboratories) was  used as a carrier to
detect hantavirus-speciﬁc IgG antibody.
Groups of sera from HFRS patients, PUUV infected patients and
HPS patients were used to evaluate the different types of ICG strip.
All of the ICG test strips showed high sensitivities (80–100%) to
homologous patient sera. Because of the antigenic cross reactivity,
on the three-line strips, sera from PUUV-infected patients and HPS
patients showed weaker ICG lines to the heterologous antigen than
to the homologous antigen. Therefore, it is easy to distinguish a
homologous reaction. Diluted whole blood specimens were appli-
cable to the ICG test as were specimens of diluted rodent blood.
The sensitivities and speciﬁcities of ICG strips were almost the
same among the different ICG types. Therefore, the type of ICG
strip should be selected according to the purpose of the survey.
For example, the three-line strip should be the most effective for
surveys in a country where no previous case of hantavirus infec-
tion has been reported or where multiple hantaviruses co-exist. The
mixed-line strip can be combined with other antigens of causative
agents of febrile infectious diseases. The combination of antigens
would allow effective surveillance of multiple infectious diseases
simultaneously. In addition, the one-antigen strip would be use-
ful for surveillance in an area where the prevalent hantavirus type
has already been determined. An ICG strip to detect IgM antibody
against PUUV and ANDV infection has been reported (Hujakka et al.,
2001a; Navarrete et al., 2007). Our ICG strips were developed for IgG
antibody detection for the purpose of retrospective seroepidemio-
logical study. However, since IgM detection is crucial for diagnosis
of the causative agent of the disease, both IgM and IgG detection ICG
strips will be necessary to obtain reliable epidemiological results.
Based on the results of the recombinant antigen-based ELISA
test and the ICG strip test, we  propose the following strategies for
diagnosis of hantavirus infection (Fig. 7). First, serological screening
should be carried out ELISA or the ICG strip test with N-terminal
103 aa of N protein of hantaviruses from one of each group A, B and
C as antigens. HTNV/SEOV, PUUV and ANDV would be selected as
representative virus (numbers from 1 to 4 in the closed circle in
Figs. 1 and 7). TPMV might be a representative virus for group D
viruses. Then for the positive sera in group A or group C antigens
should be further examined for serotyping by ELISA with trN50
or trN100 antigens as an alternative method for the neutralization
test. So far, a total of 7 different trN antigens (numbers from 1 to
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 in the open circle in Figs. 1 and 7) were available for serotyping
ntigens. Recently, recombinant N antigen of ASAV and TPMV were
roduced. Antigenicity of N protein of ASAV and TPMV might be dis-
inct, because monoclonal antibodies against TPMV N did not bind
o rN of ASAV (Schlegel et al., 2012). Therefore, it is expected that
PMV and ASAV N-terminal region of N protein would be applied
o screen antibodies against all the group D and E viruses. Further
tudies on antigenic comparison among viruses in groups D and E
ere necessary.
. Concluding remarks
In this chapter, we introduced an example of application of
he structural characteristics of a viral protein to diagnosis. Han-
aviruses are maintained by various animals in nature. Recent
etection of newly isolated hantaviruses indicated that unrecog-
ized hantaviruses one might be a human pathogen would exist
n nature. Therefore, further surveillance of hantavirus infection
mong various animals is necessary. Since the structure of N protein
s common among previously identiﬁed hantaviruses, serological
xamination based on the N-terminal immunodominant region
ight be a useful tool for elucidating the ecology of hantavirus in
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